Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Hematopoietic Stem Cell Transplantation, Virus-based gene therapy research, and Immune Cell Function and Interaction.
Prime Editing for p47 <sup>phox</sup> -Deficient Chronic Granulomatous Disease
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging
Human germline heterozygous gain-of-function <i>STAT6</i> variants cause severe allergic disease
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study
Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?
Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT
International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome
Lentiviral gene therapy for X-linked chronic granulomatous disease
Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient
The evolution of cellular deficiency in GATA2 mutation
Wilms’ Tumour 1 (<scp>WT</scp>1) peptide vaccination in patients with acute myeloid leukaemia induces short‐lived <scp>WT</scp>1‐specific immune responses
Comparison of Lentiviral and Sleeping Beauty Mediated αβ T Cell Receptor Gene Transfer